Mice Lacking an Immune Alarm Lost Less Muscle on Chemo
Graded Preliminary — experiments in young male mice given four days of chemotherapy; whether this applies to people with cancer was not studied.
Animal study. Findings may not carry over to people, which is why the grade is capped at Preliminary.
- Design
- Animal study
- Participants
- 57
- Duration
- 1 week
- Funding
- National Natural Science Foundation of China; Guangdong Province research funds
Mice lacking the cGAS-STING alarm system lost less body weight and muscle during cisplatin chemotherapy.
Cisplatin is a widely used chemotherapy drug against cancer. It often makes muscles waste away, which weakens patients physically. A study in mice now points to an alarm system of the immune defence inside cells, called cGAS-STING. Mice missing either of its two genes lost less body weight and less muscle during chemo.
The researchers gave young male mice cisplatin once a day for four days. When the animals first got a drug that switches STING on, they lost more weight and muscle. When the cGAS gene was missing only in muscle, the muscles stayed heavier and the fibres thicker. The cross-sectional area of the fibres, however, showed no clear difference. In these muscles, genes tied to muscle wasting were less active. Inflammation signals were weaker, and key regulators of muscle building held up better.
These results come from mice and a short treatment only. Whether blocking this pathway helps people having chemotherapy was not tested. The authors see it as a possible target for future treatments. Some processes, such as the cell's recycling system, were measured only indirectly.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
